New
Trackinsight is part of ETF One, the fully integrated ETF platform of Kepler Cheuvreux. Learn more →
Help us improve your experience. Please confirm your investor type:
Compare ETFs Easily
The Ultimate ETF Comparison Tool - Try Now!
Analyze up to 5 ETFs side-by-side and gain instant insights on performance, fees, holdings, and more to make data-driven investment decisions.
244580 ETF · Samsung KODEX Biotech ETF
The 244580 Exchange Traded Fund (ETF) is provided by Samsung Asset Management. It is built to track an index: FnGuide Inc Bio Index. The 244580 ETF provides physical exposure, so by buying it you actually own parts of all the 40 underlying holdings. This share class generates a stream of income by distributing dividends.
Last update Yesterday at 12:00 AM UTC
LIVE
CLOSED
This fund is part ofAPAC Blended Cap1M perf.-3.67%
Last price
â‚©13,470
1M perf.
-1.07%
1M flows
-€4.6M
AuM
€172M
E/R
0.45%
Rating
Not rated
ESG Consensus®
244580
â‚©13,470
Performance & flows
Segment for quartile rank
December 11, 2025 → March 11, 2026
Create a free account to view the flows graph
244580
â‚©12,972.05
-0.11%
APAC Blended Cap
+9.55%
Historic performance and flows
| 1M | 3M | 1Y | 3Y | 5Y | MTD | QTD | YTD | ||
|---|---|---|---|---|---|---|---|---|---|
| Perf. | -1.07%  | -0.11%  | +60.24% | +70.91% | -7.10% | -8.54% | +3.70% | +3.70%  | |
| Flows |
Key fund info
Segment for quartile rank
This ETF's jurisdiction country is not in your region (Europe and Middle East) ·
Main characteristics
Issuer
ISIN
KR7244580007
AuM
€172M
E/R
0.45%
Replication rating
Not rated
ESG Consensus®
More details
NAV
3/11/2026
â‚©12,972.05
1D NAV change
-2.45%
Dividend policy
Replication method
Direct (Physical)
Replication model
Full replication
No. of holdings
40
Inception date
5/12/2016
Jurisdiction
South Korea
Distribution
South Korea
Legal structure
Open-end Investment Trust
Base currency
KRW
Dividend distribution
Trailing 12-month distr. yield
Distribution frequency
Last distribution
Create a free account to view dividend distribution
Classification
Investment strategy
KODEX Biotech ETF invests in stocks of FnGuide Bio Index composed of both KOSPI and KOSDAQ stocks related to biotech industry.
Tax optimisation
PEA
France
UK Reporting Status
United Kingdom
Create a free Trackinsight Essentials account to unlock insights
Access exclusive metrics and features to support your investment decisions.
Built for professionals: access exclusive fund metrics and selection tools in Trackinsight Enterprise.
Enterprise Fund page features include:
Legal documents
Powerful buy-list integration
Fund data exports
Advanced risk metrics
Advanced replication analysis
Advanced exposure look-through
Upload your own internal metrics
Custom data feature
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseAdvertisement
Risk profile
Segment for quartile rank
Historical risk/return profile
| 3M | 1Y | 3Y | 5Y | |
|---|---|---|---|---|
| Returns | -0.11% | +60.24% | +70.91% | -7.10% |
| Volatility | ||||
| Perf./Volatility | ||||
| Max drawdown |
Create a free account to view risk/return table
Synthetic Risk and Reward Indicator (SRRI)
UCITS
N/A
PRIIPS
N/A
Built for professionals: access exclusive risk metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseExposure
Countries
Republic of Korea
80.73%
Unavailable
19.27%
Sectors
Health Care
60.05%
Consumer Discretionary
2.42%
Unavailable
37.53%
Diversification
Total weight of top 15 holdings out of 40
Top 15 holdings
Data as of January 31, 2026
SAM CHUN DANG PH
PHARMARESEARCH CO LTD
KR7397030008
HLB
HUGEL
CELLTRION
KR70126Z0002
WON TECH CO.
Create a free account to view top holdings
HANMI SCIENCE
ST PHARM
SAMSUNG BIOLOGICS CO LTD
CHABIOTECH CO LTD
CLASSYS INC
KR7328130000
CELLTRION PHARM
Create a free account to view top holdings
Built for professionals: access exclusive exposure metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseSustainability
Integrates ESG criteria
No
SDG
Built for professionals: access exclusive sustainability metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseReplication
Trackinsight replication rating:
Not rated
Replication quality
Calculated over 12m, as of February 27, 2026
Tracking error
Tracking difference
Replication information
Index
FnGuide Inc Bio Index - KRW
Index ticker
FNGDBIOI Index
Index dividend policy
PI
Replication method
Replication model
Built for professionals: access exclusive replication metrics in Trackinsight Enterprise.
Enterprise
Trackinsight Enterprise helps professional and institutional ETF investors tackle operational, regulatory, and analytical challenges at every stage of the investment process.
Learn more about Trackinsight EnterpriseIssuer
Samsung Asset Management
Samsung Asset Management ID Card
Number of funds
145
Total AuM
€58.24B
Expense ratio range
0.015% - 2.28%
Average expense ratio
0.3679%
Top 5 funds by Samsung Asset Management
| AuM | ||
|---|---|---|
069500 | Samsung KODEX 200 ETF | €10.53B |
379800 | KODEX S&P500 TR | €4.76B |
459580 | Samsung Kodex CD Rate Active(SYNTH) ETF | €4.74B |
229200 | Samsung KODEX KOSDAQ 150 ETF | €4.29B |
278530 | Samsung KODEX 200 Total Return ETF | €3.33B |
Frequently asked questions about 244580
What does Samsung KODEX Biotech ETF, 244580, invest in?
244580 is a Passive ETF. This ETF provides exposure to Equally Weighted South Korean Biotechnology Equities.
Which benchmark or index does 244580 replicate?
244580 tracks the FnGuide Inc Bio Index - KRW, through a full replication replication method.
What is the Total Expense ratio (TER) of 244580?
244580 carries a total expense ratio (TER) of 0.45%, indicating the annual cost for holding the fund.
When was 244580 launched?
244580 was introduced to the market on May 12, 2016. It trades on South Korea
Who is the ETF issuer of 244580?
Samsung KODEX Biotech ETF, 244580, is provided by Samsung Asset Management. Learn more about Samsung Asset Management here.
What is the current assets under management (AUM) of 244580?
244580 oversees €172M in assets as of March 11, 2026.
How has 244580 performed lately?
Based on data from March 11, 2026, 244580 returned -1.07% over the past month, -0.11% over the last three months and 3.70% year-to-date.
What are the latest inflows or outflows for 244580?
As of March 11, 2026, 244580 recorded net flows of -€4.7M over the last month and +€3.7M year-to-date.
Does 244580 distribute dividends?
244580 follows a distributing dividend policy, meaning it pays out income to investors. As of March 11, 2026, its 12-month trailing yield was 0.12%.
What are the main country or region exposures of 244580?
As of January 31, 2026, 244580 has significant geographic allocations in Republic of Korea.
In which sector or theme does 244580 invest in?
As of January 31, 2026, 244580 focuses largely on Health Care and Consumer Discretionary.
How many securities does 244580 hold and how diversified is it?
As of January 31, 2026, 244580 holds 40 positions in its portfolio, with 34.86% of assets concentrated in its top 15 holdings.
What are the main positions in 244580?
As of January 31, 2026, 244580 top three holdings include SAM CHUN DANG PH, PHARMARESEARCH CO LTD and KR7397030008.
What is the base currency of 244580?
The base currency of 244580 is KRW.
Advertisement
About Trackinsight
Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.
Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.
In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.
This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.
Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.
More about TrackinsightETF TOOLS
PLATFORM
ETF NEWS & RESEARCH
© 2014-2026 Trackinsight SA. All rights reserved.
Privacy policy | Cookie policy | | Terms of use | Imprint
Privacy policy | Cookie policy | | Terms of use | Imprint
